Nicholas J. Pritzker highlights TWST as a biotech standout with 45.67% upside potential

From Yahoo Finance: 2025-05-08 23:43:00

Nicholas J. Pritzker, chairman of Tao Capital Partners, is known for strategic investments in technology, transportation, healthcare, and more. Although not the portfolio manager, Pritzker’s guidance influences the firm’s sustainable ventures. As of Q4 2024, Tao Capital managed $143.28 million in 13F securities across ten core holdings, aligning with Pritzker’s vision of impactful investing.

In analyzing Nicholas J. Pritzker’s stock picks, Twist Bioscience Corporation (TWST) emerges as a standout biotech company with a unique approach to synthetic DNA manufacturing. Despite a revenue beat, TWST faces challenges with profitability and scaling operations. With a market cap of $2.39 billion and institutional ownership at 112.29%, TWST shows promise in the biotech space with a 45.67% upside potential.

Overall, TWST ranks 2nd among Pritzker’s stock picks, with AI stocks offering potentially higher returns in a shorter timeframe. Despite TWST’s potential, exploring undervalued AI stocks may present more promising opportunities for investors looking to capitalize on the evolving tech landscape.

For more insights on AI stocks and billionaire investment strategies, visit Insider Monkey for detailed analysis and recommendations.



Read more at Yahoo Finance: Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential